Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
331
mi
from 43215
Nashville, TN
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
362
mi
from 43215
Tullahoma, TN
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
362
mi
from 43215
Tullahoma, TN
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
925
mi
from 43215
Beaumont, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
925
mi
from 43215
Beaumont, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
910
mi
from 43215
Dallas, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
994
mi
from 43215
Galveston, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
994
mi
from 43215
Galveston, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1130
mi
from 43215
Lubbock, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1130
mi
from 43215
Lubbock, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1214
mi
from 43215
Odessa, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1214
mi
from 43215
Odessa, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
862
mi
from 43215
Tyler, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
862
mi
from 43215
Tyler, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
335
mi
from 43215
Midlothian, VA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
335
mi
from 43215
Midlothian, VA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
251
mi
from 43215
Roanoke, VA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
251
mi
from 43215
Roanoke, VA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2000
mi
from 43215
Kirkland, WA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2000
mi
from 43215
Kirkland, WA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2012
mi
from 43215
Tacoma, WA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2012
mi
from 43215
Tacoma, WA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
394
mi
from 43215
Madison, WI
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
5398
mi
from 43215
Adrogué,
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
5398
mi
from 43215
Adrogué,
Click here to add this to my saved trials
Database Registry of the Intermountain Heart Collaborative Study
Database Registry of the Intermountain Heart Collaborative Study
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
1515
mi
from 43215
Murray, UT
Database Registry of the Intermountain Heart Collaborative Study
Database Registry of the Intermountain Heart Collaborative Study
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
1515
mi
from 43215
Murray, UT
Click here to add this to my saved trials
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
OV-UCLA Medical Center
1975
mi
from 43215
Sylmar, CA
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
OV-UCLA Medical Center
1975
mi
from 43215
Sylmar, CA
Click here to add this to my saved trials
Cardiovascular Disease Screening
Suburban/NHLBI Cardiovascular Disease Screening Protocol
Status: Enrolling
Updated:  12/31/1969
Suburban Hospital
323
mi
from 43215
Bethesda, MD
Cardiovascular Disease Screening
Suburban/NHLBI Cardiovascular Disease Screening Protocol
Status: Enrolling
Updated: 12/31/1969
Suburban Hospital
323
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Cardiovascular Disease Screening
Suburban/NHLBI Cardiovascular Disease Screening Protocol
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Cardiovascular Disease Screening
Suburban/NHLBI Cardiovascular Disease Screening Protocol
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Effect of Diet on Vascular Disease in Pre-Menopausal Women
The Effect of Diet on Vascular Disease: A Study of African American and Caucasian Women
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Effect of Diet on Vascular Disease in Pre-Menopausal Women
The Effect of Diet on Vascular Disease: A Study of African American and Caucasian Women
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Alaska Regional Hospital and Alaska Cardiovascular Research Foundation, LLC
mi
from 43215
Anchorage, AK
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Alaska Regional Hospital and Alaska Cardiovascular Research Foundation, LLC
mi
from 43215
Anchorage, AK
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
University of Arizona
1639
mi
from 43215
Tucson, AZ
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
University of Arizona
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Glendale Memorial Hospital and Health Center
1970
mi
from 43215
Glendale, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Glendale Memorial Hospital and Health Center
1970
mi
from 43215
Glendale, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Long Beach Memorial Medical Center
1976
mi
from 43215
Long Beach, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Long Beach Memorial Medical Center
1976
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Hollywood Presbyterian Medical Center
1973
mi
from 43215
Los Angeles, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Hollywood Presbyterian Medical Center
1973
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
UCLA Medical Center
1982
mi
from 43215
Los Angeles, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
UCLA Medical Center
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Hoag Memorial Hospital Presbyterian and Radin Inc.
mi
from 43215
Newport Beach, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Hoag Memorial Hospital Presbyterian and Radin Inc.
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Catholic Healthcare West (d/b/a mercy General Hospital) and Regional Cardiology Associates
mi
from 43215
Sacramento, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Catholic Healthcare West (d/b/a mercy General Hospital) and Regional Cardiology Associates
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cardiovascular Associates
mi
from 43215
Denver, CO
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cardiovascular Associates
mi
from 43215
Denver, CO
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
University of Florida-Shands/Jacksonville
668
mi
from 43215
Jacksonville, FL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
University of Florida-Shands/Jacksonville
668
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Orlando Regional Healthcare System
795
mi
from 43215
Orlando, FL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Orlando Regional Healthcare System
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Cardiology Consultants of Northwest Florida
700
mi
from 43215
Pensacola, FL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Cardiology Consultants of Northwest Florida
700
mi
from 43215
Pensacola, FL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Northeast Georgia Heart Center
394
mi
from 43215
Gainesville, GA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Northeast Georgia Heart Center
394
mi
from 43215
Gainesville, GA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Midwest Heart Foundation
292
mi
from 43215
Lombard, IL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Midwest Heart Foundation
292
mi
from 43215
Lombard, IL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Lutheran Hospital of Indiana and Northern Indiana Research Alliance of the Heart Center Medical Group
mi
from 43215
Fort Wayne, IN
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Lutheran Hospital of Indiana and Northern Indiana Research Alliance of the Heart Center Medical Group
mi
from 43215
Fort Wayne, IN
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
The Care Group, LLC
167
mi
from 43215
Indianapolis, IN
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
The Care Group, LLC
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Kentucky Heart Institute / King's Daughter
105
mi
from 43215
Ashland, KY
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Kentucky Heart Institute / King's Daughter
105
mi
from 43215
Ashland, KY
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Baptist Healthcare System Inc. (d/b/a Central Baptist Hospital)
mi
from 43215
Lexington, KY
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Baptist Healthcare System Inc. (d/b/a Central Baptist Hospital)
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins
345
mi
from 43215
Baltimore, MD
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
MedStar Research Institute (Washington Hospital Center)
329
mi
from 43215
Hyattsville, MD
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
MedStar Research Institute (Washington Hospital Center)
329
mi
from 43215
Hyattsville, MD
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Caritas St. Elizabeth's Medical Center
643
mi
from 43215
Boston, MA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Caritas St. Elizabeth's Medical Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
165
mi
from 43215
Detroit, MI
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
165
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Advanced Cardiac Healthcare (Bronson Methodist Hospital)
mi
from 43215
Kalamazoo, MI
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Advanced Cardiac Healthcare (Bronson Methodist Hospital)
mi
from 43215
Kalamazoo, MI
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
William Beaumont Hospital
176
mi
from 43215
Royal Oak, MI
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
William Beaumont Hospital
176
mi
from 43215
Royal Oak, MI
Click here to add this to my saved trials